Sort By:
Esha Gupta
Via
Google My Business
3 years ago
Dr. Charlson is the best doctor I've ever had. I won't go into the saga of the situation I have been experiencing for the past 1.5 years with my eye, but let's just say I've seen SEVERAL doctors, had an invasive procedure done, been on and off antibiotics, done so many warm compresses it should be my part-time job and even had multiple steroid shots in my eyes. Nothing and no one helped me, except Dr. Chalrson. When she got on the case, my eye finally started to improve. She is just amazing. She listens so patiently and always answers ALL questions super-thoroughly. I never feel like I'm wasting her time or bothering her with unnecessary thoughts or questions. She really cares, and she's damn good at her job. I wish she could be my doctor for everything! THANK YOU Dr. Charlson!
helen hughes
Via
Google My Business
3 years ago
Excellent explanations for my treatment, good listener, and even asked me if I had questions.
Nonna Ruzina
Via
Google My Business
3 years ago
Thank you for your professional work, for the warm and friendly relations of all the staff of Pacific Eye Associates and you personally. I wish you all good health and success in your difficult and noble work. Olexandr
Peter Kay
Via
Google My Business
3 years ago
Michael Fox
Via
Google My Business
3 years ago
Attentive, professional, and caring physician !
ABOUT
Dr. Emily Sarah Charlson
Ophthalmologist Emily Charlson, M.D., Ph.D. is a specialist in oculofacial, orbital, and aesthetic plastic surgery. She is an expert in eyelid, orbit, and tear drainage surgery including droopy eyelids and eyebrows, eyelid bags, eyelid cancer/Mohs reconstruction, eyelid malpositions, thyroid eye disease/decompression, orbital tumors or masses, and tearing due to tear drainage system problems.
Dr. Charlson implements the latest medical and surgical therapies including biologics for orbital carcinoma, corneal neurotization (nerve grafting) to restore corneal sensation, and Teprotumumab for thyroid eye disease treatment. Cosmetically, she performs aesthetic eyelid, eyebrow, and midface surgery, as well as injectable fillers/botox and skin resurfacing for full facial rejuvenation. Using the latest minimally invasive techniques, she strives to balance eye function and aesthetics with patient-centered customized approaches.
Dr. Charlson graduated from The University of Pennsylvania after a 7-year dual degree MD-PhD medical scientist training program. Her Ph.D. work centered on genomics, deep-sequencing, and bioinformatics with the Human Microbiome Project.
She presented her work at numerous national and international conferences with publications in Nature Biotechnology, Nature Methods, and others. Her work is recognized with the University of Pennsylvania Institute for Translational Medicine & Therapeutics Prize for Clinical Translational Research and Jeffery W. Berger Ophthalmology Research Award, among others.
She completed her ophthalmology residency at the University of California, Irvine. Here, Dr. Charlson led the development of a novel digital prosthetic eye using OLED micro-screens and 3D printed glasses incorporating a convolutional neural network artificial intelligence algorithm for pupil tracking funded by an Institute for Clinical Translational Research Rising Investigator NIH Grant.
This work was presented at several international conferences and recognized with a UCI Research Excellence Award and American Society of Ophthalmic Plastic Surgery (ASOPRS) Innovation & Achievement Award.
Dr. Charlson pursued an intensive 2-year American Society of Ophthalmic Plastic Surgery fellowship in oculofacial, orbit, and aesthetics as of one of only a handful of fellows annually selected by ASOPRS with Byers Eye Institute at Stanford University.
She received a Heed Fellowship Award from the Society of Heed Fellows and lead significant contributions to survival analysis of globe/eye salvaging therapy for orbital malignancy, use of immune-checkpoint inhibitors for advanced orbital carcinoma, and new methods of corneal neurotization.
Most recently, she designed novel artificial intelligence algorithms to predict thyroid eye disease development in newly diagnosed Graves’ and Hashimoto’s disease patients useful for evaluating the risk of thyroidectomy vs radioactive iodine ablation (RAI) in thyroid patients. This work was recognized at international conferences and awarded the ASOPRS Innovation & Achievement Award.
Outside of medicine, she loves running/swimming/cycling as a triathlete, taking her two Rhodesian Ridgeback puppies to the beach, and traveling internationally with her family.